I
Isu Abxis Co Ltd
KOSDAQ:086890
Isu Abxis Co Ltd
KOSDAQ:086890
Price:
4 830
KRW
0.84%
Market Cap:
₩196.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Isu Abxis Co Ltd
KOSDAQ:086890
|
KR |
|
Good Drinks Australia Ltd
ASX:GDA
|
AU |
|
S
|
Smart Logistics Global Ltd
NASDAQ:SLGB
|
HK |
|
K
|
KR Motors Co Ltd
KRX:000040
|
KR |
|
Banca Mediolanum SpA
MIL:BMED
|
IT |
|
J
|
Jiangsu Tongli Risheng Machinery Co Ltd
SSE:605286
|
CN |
|
MSA Safety Inc
NYSE:MSA
|
US |
|
Cosmopolitan International Holdings Ltd
HKEX:120
|
HK |
|
A
|
Artifex Mundi SA
WSE:ART
|
PL |
|
S
|
Segar Kumala Indonesia Tbk PT
IDX:BUAH
|
ID |
|
Phoenix Tours International Inc
TWSE:5706
|
TW |
|
A
|
Anhui XDLK Microsystem Corp Ltd
SSE:688582
|
CN |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
EnTie Commercial Bank Ltd
TWSE:2849
|
TW |
Multiples-Based Value
The Multiples-Based Value of one Isu Abxis Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 4 830 KRW, Isu Abxis Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Isu Abxis Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Isu Abxis Co Ltd Competitors
Isu Abxis Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
I
|
Isu Abxis Co Ltd
KOSDAQ:086890
|
195.9B KRW | 3.5 | -18.3 | 27.8 | 106.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.5 | 42.8 | 43.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
